Who founded NeuroEM Therapeutics?

NeuroEM Therapeutics was founded by Gary Arendash.

How much funding has NeuroEM Therapeutics raised?

NeuroEM Therapeutics has disclosed $2.3M raised across 2 rounds.

Where is NeuroEM Therapeutics headquartered?

NeuroEM Therapeutics is headquartered in Tampa, US.

NeuroEM Therapeutics

Tampa, US · Delaware corporation · 11 employees on LinkedIn

NeuroEM Therapeutics develops MemorEM, a wearable head device that administers transcranial electromagnetic treatment to treat cognitive decline and Alzheimer's disease. The device targets patients with neurodegenerative diseases through a non-invasive, in-home treatment delivered by healthcare professionals.

Deep Tech Healthtech Medical Devices

Founders & leadership

Gary ArendashinFounder & Scientist Emeritus

Chuck PapageorgiouinChief Executive Officer

Board

Mitch LarimoreBoard director

Jonathan GordonBoard director

Reported raises · per SEC filings

Form D private placements

$2.3M disclosed across 2 rounds · 2024–2025

▶$1.9MraisedApr 2025 · 23 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Chuck PapageorgiouExecutive Officer, Director
Mitch LarimoreDirector
Jonathan GordonDirector

Offering amount: $6.5M
Amount sold: $1.9M
First sale: Apr 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$360KraisedJun 2024 · 12 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Chuck PapageorgiouExecutive Officer, Director
Mitch LarimoreDirector
Jonathan GordonDirector

Offering amount: $500K
Amount sold: $360K
First sale: May 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2021	$2.1M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2017	$255.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

NeuroEM Closes Initial Round for Radio Wave Alzheimer's Treatment | StartUp Health Insights: Week of Jun 17, 2025 – RamaOnHealthcareramaonhealthcare.com · Jun 2025

NeuroEM Therapeutics Secures $1.33 Million in Series A Funding to Advance Drug-Free Alzheimer's Treatmenttrial.medpath.com · Jun 2025

NeuroEM Therapeutics(R) Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer's Treatmentfinance.yahoo.com · Jun 2025

NeuroEM Therapeutics Emerges from Chapter 11 with a Stronger Vision, New Leadership, and Renewed Focus on Growthfinance.yahoo.com · Nov 2023

Frequently asked questions

What does NeuroEM Therapeutics do?: NeuroEM Therapeutics develops MemorEM, a wearable head device that administers transcranial electromagnetic treatment to treat cognitive decline and Alzheimer's disease. The device targets patients with neurodegenerative diseases through a non-invasive, in-home treatment delivered by healthcare professionals.
Who founded NeuroEM Therapeutics?: NeuroEM Therapeutics was founded by Gary Arendash.
How much funding has NeuroEM Therapeutics raised?: NeuroEM Therapeutics has disclosed $2.3M raised across 2 rounds.
Where is NeuroEM Therapeutics headquartered?: NeuroEM Therapeutics is headquartered in Tampa, US.